The 3D printing market arrives!
The Global 3D printing market is estimated to grow quickly
spurred by tissue engineering and dental implants.
Source: ”3D Printing in Healthcare Market - By Material
(Donor Cells, Plastics, Metals, Ceramics, Bone Cement); By
Application (Implants, Tissue Engineering, Surgical Guides,
Hearing Aids, Dental Implants, Medical Components) —
Forecast (2015 to 2020)”, IndustryArc, April 14, 2016.
The FDA is getting faster?
27 of the 45 novel drugs approved in 2015 by the FDA
were designated in one or more expedited categories
to help speed the development and/or approval
process. These include Alecensa, Avycaz, Bridion,
Cholbam, Corlanor, Cotellic, Cresemba, Daklinza,
Darzalex, Empliciti, Entresto, Farydak, Genvoya,
Ibrance, Kanuma, Lenvima, Lonsurf, Ninlaro, Orkambi,
Portrazza, Praxbind, Strensiq, Tagrisso, Unituxin,
Viberzi, Xuriden, and Yondelis.
Source: “2015 Novel Drugs Summary” January 2016,
US Food and Drug Administration, Center for Drug
Evaluation and Research.
Medical device company outlooks are positive.
82% of the survey participants in Emergo’s recent Medical Device
Industry Outlook had a positive outlook for 2016. The strongest
growth is expected by those in North America for the US, 42%, and
those in Europe and Asia for China, 30% and 49% respectively.
Source: Medical Device and Insutry Outlook, Emergo, January 2016.